New Century Healthcare (HKG:1518) expects to have recorded an attributable profit of between 35 million yuan and 50 million yuan in 2024, down from 84.2 million yuan a year prior, a Monday filing by the healthcare provider with the Hong Kong bourse said.
The company attributed the anticipated profit slump to a sharp drop in demand for its pediatric internal medicine services in 2024.
In 2023, New Century Healthcare said it experienced a surge in patient volume driven by a widespread outbreak of pediatric infections. However, this momentum has not been sustained last year.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。